Newsletter

Generalized Myasthenia Gravis
A chronic autoimmune neuromuscular disease with almost 55% of the cases diagnosed in the US in the 7MM, gMG has managed to garner the attention of several pharma companies
Generalized Myasthenia Gravis

More Whitepapers / Newsletters

Impact of BREXIT on Pharma Space Newsletter
Impact of BREXIT on Pharma Space

BREXIT, the 'EXIT' of 'BRITAIN' from 'EUROPEAN UNION', shook the whole world when the United Kingdom voted in the favor of leaving the EU.

Gaucher Disease Newsletter
Gaucher Disease

The most common lysosomal disease, Gaucher Disease is a result of lack of sufficient glucocerebrosidase (GCase), an enzyme required..

Fibrodysplasia Ossificans Progressiva Whitepaper
Fibrodysplasia Ossificans Progressiva

Fibrodysplasia Ossificans Progressiva (FOP) is a rare disorder that results in gradual ossification of the connective...

ASCO Reveals: Increasing Options for Relapse/ Refractory Patients in Haematological Malignancies Whitepaper
ASCO Reveals: Increasing Options for Relapse/ Refractory Patients in Haematological Malignancies

Immunotherapies, a potentially life-saving therapy, have benefitted several patients suffering from cancer help...

Cancer in The United States(Vol 1, Issue 2) Newsletter
Cancer in The United States(Vol 1, Issue 2)

US Cancer Statistics show that more than half a million suffer from this disease, which is the second leading cause of death in the country.